KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED
Company Overview
Total Bids
1
Contract Value
₹4.29 Lakh
L1 Bids
0
Historical Bids (Since 2018)
1
Participated Tenders
Ayurvedic Classical Medicines - Taila,Ayurvedic Classical Medicines - Avaleha and Pak,Ayurvedic Cla
Karnataka Antibiotics And Pharmaceuticals Limited has begun establishing a presence in India's government tender ecosystem with participation in 1 tenders between April 2018 and March 2025. This analysis examines their early tender participation, technical qualification rate, and emerging procurement strategy. Key performance indicators are assessed using TenderAI’s proprietary algorithm.
During FY2024-25, Karnataka Antibiotics And Pharmaceuticals Limited showcased a 100.0% qualification rate, successfully qualifying for 1 out of 1 tenders. Their financial health assessment shows a 'Critical' status with a score of 22.5/100, indicating potential areas for improvement. Their initial market positioning focuses on serving the Ministry of Labour and Employment.
This Karnataka Antibiotics And Pharmaceuticals Limited report provides a detailed SWOT analysis and strategic recommendations to enhance their tender performance and overall competitiveness within the Indian government procurement landscape. The company operates in the pharmaceutical sector, making them a critical pharmaceutical supplier for government entities.
Financial Performance Analysis
Yearly Trends
Karnataka Antibiotics And Pharmaceuticals Limited's tender participation began in FY2024-25, with 1 bid submitted. The company's total contract value for this period reached ₹4,28,676. There is no historical data available for FY2018-19 through FY2023-24 as the company didn't participate in any tenders during these years. The financial health score is rated as Critical (22.5/100) based on TenderAI scoring components, and indicating areas needing improvement.
| Fiscal Year | Bid Count | Win Count | Qualification Rate | Win Rate | Total Contract Value |
|---|---|---|---|---|---|
| FY 2018-19 | 0 | 0 | 0.0% | 0.0% | ₹0 |
| FY 2019-20 | 0 | 0 | 0.0% | 0.0% | ₹0 |
| FY 2020-21 | 0 | 0 | 0.0% | 0.0% | ₹0 |
| FY 2021-22 | 0 | 0 | 0.0% | 0.0% | ₹0 |
| FY 2022-23 | 0 | 0 | 0.0% | 0.0% | ₹0 |
| FY 2023-24 | 0 | 0 | 0.0% | 0.0% | ₹0 |
| FY 2024-25 | 1 | 0 | 100.0% | 0.0% | ₹4,28,676 |
From April 2023 to March 2024, Karnataka Antibiotics And Pharmaceuticals Limited's bid distribution shows that 100% of bids fall within the lowest price range (₹0). This indicates the company's initial focus on smaller-value tenders. A visual representation of bid distribution across different price ranges would offer further insights.
Product/Service Category Performance
Currently, there is limited category-specific performance data available, as the company's participation is concentrated on a single "NA" department. Further diversification across different categories is recommended to assess performance variations and identify potential areas of specialization.
Geographical & Departmental Distribution
Departmental Distribution
The company has primarily focused on the NA department, with 1 tender participation. Expanding reach to other departments could provide diversification and growth opportunities.
Ministry Analysis
Karnataka Antibiotics And Pharmaceuticals Limited's initial engagement is with the Ministry of Labour and Employment. Further ministry diversification can broaden the company's market presence.
Competitive Analysis
Head-to-Head Comparison
From January 2022 to December 2023, HLL LIFECARE LIMITED emerges as a direct competitor, having been encountered in 1 tender, and winning that tender. Karnataka Antibiotics And Pharmaceuticals Limited needs to develop strategies to compete effectively against established players.
| Competitor | Encounter Count | Win Rate |
|---|---|---|
| HLL LIFECARE LIMITED | 1 | 100.0% |
| KARNATAKA ANTIBIOTICS ... | 1 | 0.0% |
Compared to HLL LIFECARE LIMITED, Karnataka Antibiotics And Pharmaceuticals Limited needs to improve its win rate and overall competitive position to secure more government contracts.
SWOT Analysis of Karnataka Antibiotics And Pharmaceuticals Limited
Strengths
- High technical qualification rate (100.0%)
Weaknesses
- Low win rate (0.0%) indicates competitive challenges
- Concentrated participation in a single department (NA)
Opportunities
- Explore growth potential in high-value projects and new departments/ministries
- Optimize bid pricing strategy based on historical win rates by value range
Threats
- Intense competition from established players like HLL LIFECARE LIMITED
- Limited diversification across different categories and ministries
Strategic Recommendations
- Implement a more selective bid strategy focusing on winnable tenders.
- Establish a pre-bid qualification process to improve the bid-to-win ratio.
- Create a market expansion strategy targeting new customer segments.
- Establish a bid review committee to improve tender selection and proposal quality.
- Enhance proposal quality through better compliance, technical, and commercial optimization.
Future Growth Outlook
Based on the current trend and sector dynamics, Karnataka Antibiotics And Pharmaceuticals Limited has potential for growth if strategic recommendations are implemented effectively. Diversifying into new categories and ministries, along with improving the win rate, will be crucial for long-term success in the Indian government tender landscape.